Atlas Trials

Efficacy and Safety Comparison of Upadacitinib and Vedolizumab in Second-line Treatment for Crohn's Disease

Clinical trial NCT06446219 · COMPLETED

Trial details

NCT number
NCT06446219
Sponsor
Sixth Affiliated Hospital, Sun Yat-sen University
Status
COMPLETED
Study type
OBSERVATIONAL
Crohn Disease
Start date
2020-01-01
Primary completion
2024-03-31
Enrollment
172

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.